Heat and the Brain: GLP-1s Have a Stranger Side Effect Than Anyone Expected
Consider this: researchers studying GLP-1 users have found changes in taste and smell perception.
There is a particular kind of summer heat that arrives in Mediterranean cities not as weather but as atmosphere — heavy, golden, pressing against everything. In Valletta in July, it settles into the stone by mid-morning and doesn't leave until long after dark. You learn to move differently in it. You drink before you're thirsty. You slow down. Your body negotiates.
Which is why the emerging picture around GLP-1 medications and heat struck me as something worth sitting with — not the dehydration risk, which has been covered — but the stranger, quieter findings circling these drugs right now, the ones that don't fit neatly into the weight-loss headline.
Consider this: researchers studying GLP-1 users have found changes in taste and smell perception. Some users report foods they loved now register as flat, or wrong. The mechanism is still being mapped, but GLP-1 receptors exist in neural tissue, not just in the gut — and the brain's relationship to appetite is far more sensory, far more emotional, than we typically acknowledge. The drug doesn't just tell your stomach it's full. It converses with the parts of you that make food meaningful.
Then there's the finding that genuinely surprised me: GLP-1 medications appear linked to measurable reductions in impulsivity and violent behaviour in adults. The same neural pathways that regulate hunger also, apparently, have something to say about how we manage anger and craving more broadly. Addiction researchers have been watching this with considerable interest. The drug's mechanism — dampening the reward signal — doesn't discriminate neatly between a second helping and a third drink.
And yet: people using these medications are, according to one study, less likely to exercise. Not because they can't. Because the appetite for movement — which is also, in part, a reward-driven behaviour — seems to quiet alongside everything else. The drug delivers results without demanding effort, and the brain, ever efficient, accepts the arrangement.
What this adds up to is a molecule that is doing considerably more than managing blood sugar or reducing waistlines. It is reaching into how we experience pleasure, craving, sensation, and impulse. That is not an argument against it — for many people, these drugs are genuinely transformative — but it is an argument for paying attention to the whole self while taking them, not just the number on the scale.
The body is not a collection of separate systems. It is one conversation.
One thing to do: If you or someone you know is using a GLP-1 medication, schedule a deliberate, structured walk into the week — not for calories, but as a way of keeping movement wired into the routine before the appetite for it goes quiet.
